NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,125 filers reported holding NOVARTIS A G in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $290 | -99.9% | 2,842 | +1.5% | 0.07% | +16.1% |
| Q2 2023 | $250,386 | -41.2% | 2,800 | -41.4% | 0.06% | -29.5% |
| Q1 2023 | $425,956 | +65.1% | 4,780 | +51.9% | 0.09% | -4.3% |
| Q3 2021 | $258,000 | +13.7% | 3,147 | +26.6% | 0.09% | +4.5% |
| Q2 2021 | $227,000 | +7.1% | 2,486 | +4.9% | 0.09% | -15.4% |
| Q1 2021 | $212,000 | 0.0% | 2,371 | 0.0% | 0.10% | 0.0% |
| Q4 2020 | $212,000 | +7.1% | 2,371 | +4.0% | 0.10% | -11.1% |
| Q3 2020 | $198,000 | +29.4% | 2,280 | +30.2% | 0.12% | +8.3% |
| Q2 2020 | $153,000 | +13.3% | 1,751 | +6.8% | 0.11% | -8.5% |
| Q1 2020 | $135,000 | -63.4% | 1,640 | -57.9% | 0.12% | -59.5% |
| Q4 2019 | $369,000 | +10.5% | 3,897 | +1.3% | 0.29% | -7.9% |
| Q3 2019 | $334,000 | -10.0% | 3,847 | -5.3% | 0.32% | -2.8% |
| Q2 2019 | $371,000 | +11.7% | 4,063 | +17.5% | 0.32% | +30.0% |
| Q1 2019 | $332,000 | +207.4% | 3,458 | +174.7% | 0.25% | +208.6% |
| Q4 2018 | $108,000 | – | 1,259 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |